ReP USP - Resultado da busca

Artigo de periodico
Pharmacological inhibition of ezrin reduces proliferative and invasive phenotype in acute lymphoblastic leukemia cells (2025)
Silva, Jean Carlos Lipreri da ; Lima, Keli ; Ede, Benjamin; Lazarini, Mariana ; Vicari, Hugo Passos ; Nogueira, Frederico Lisboa ; Clayton, Natasha S. ; Pinnell, Katy; Silva, Wellington Fernandes da ; Bendit, Israel ; Ridley, Anne J. ; Rego, Eduardo Magalhães ; Velloso, Elvira Deolinda Rodrigues Pereira ; Costa-Lotufo, Leticia Veras ; Machado Neto, João Agostinho
Source: European Journal of Pharmacology. Unidades: FM, ICB
Subjects: FARMACOLOGIA, LEUCEMIA, LINFOMA, NEOPLASIAS POR TIPO HISTOLÓGICO, CITOESQUELETO, FILAMENTOS CITOPLASMÁTICOS, ANTINEOPLÁSICOS, APOPTOSE, PROLIFERAÇÃO CELULAR, SOBREVIVÊNCIA CELULAR, ESTUDOS DE COORTES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Jean Carlos Lipreri da et al. Pharmacological inhibition of ezrin reduces proliferative and invasive phenotype in acute lymphoblastic leukemia cells. European Journal of Pharmacology, v. 987, p. 13 , 2025Tradução . . Disponível em: https://doi.org/10.1016/j.ejphar.2024.177161. Acesso em: 03 nov. 2025.
APA
Silva, J. C. L. da, Lima, K., Ede, B., Lazarini, M., Vicari, H. P., Nogueira, F. L., et al. (2025). Pharmacological inhibition of ezrin reduces proliferative and invasive phenotype in acute lymphoblastic leukemia cells. European Journal of Pharmacology, 987, 13 . doi:10.1016/j.ejphar.2024.177161
NLM
Silva JCL da, Lima K, Ede B, Lazarini M, Vicari HP, Nogueira FL, Clayton NS, Pinnell K, Silva WF da, Bendit I, Ridley AJ, Rego EM, Velloso EDRP, Costa-Lotufo LV, Machado Neto JA. Pharmacological inhibition of ezrin reduces proliferative and invasive phenotype in acute lymphoblastic leukemia cells [Internet]. European Journal of Pharmacology. 2025 ; 987 13 .[citado 2025 nov. 03 ] Available from: https://doi.org/10.1016/j.ejphar.2024.177161
Vancouver
Silva JCL da, Lima K, Ede B, Lazarini M, Vicari HP, Nogueira FL, Clayton NS, Pinnell K, Silva WF da, Bendit I, Ridley AJ, Rego EM, Velloso EDRP, Costa-Lotufo LV, Machado Neto JA. Pharmacological inhibition of ezrin reduces proliferative and invasive phenotype in acute lymphoblastic leukemia cells [Internet]. European Journal of Pharmacology. 2025 ; 987 13 .[citado 2025 nov. 03 ] Available from: https://doi.org/10.1016/j.ejphar.2024.177161
Artigo de periodico
The impact of clinical features on survival and relapse of patients diagnosed with T-cell acute lymphoblastic leukemia: a multicenter cohort study (2025)
Silva, Diego Luz Felipe da; Duarte, Bruno Kosa Lino; Oliveira, Yve Cardoso de; Piaia, Camila; Aragao, Jordana Santos Ramires; Chapchap, Eduardo Cerello; Carvalho, Maria Eduarda Alonso Joaquim de; Velloso, Elvira Deolinda Rodrigues Pereira ; Rocha, Vanderson Geraldo ; Rego, Eduardo Magalhães
Source: Clinical lymphoma myeloma & leukemia. Unidade: FM
Subjects: LEUCEMIA, LINFÓCITOS T, SOBREVIVÊNCIA LIVRE DE DOENÇA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Diego Luz Felipe da et al. The impact of clinical features on survival and relapse of patients diagnosed with T-cell acute lymphoblastic leukemia: a multicenter cohort study. Clinical lymphoma myeloma & leukemia, v. 25, n. 4, p. 258-264, 2025Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/84778. Acesso em: 03 nov. 2025.
APA
Silva, D. L. F. da, Duarte, B. K. L., Oliveira, Y. C. de, Piaia, C., Aragao, J. S. R., Chapchap, E. C., et al. (2025). The impact of clinical features on survival and relapse of patients diagnosed with T-cell acute lymphoblastic leukemia: a multicenter cohort study. Clinical lymphoma myeloma & leukemia, 25( 4), 258-264. doi:10.1016/j.clml.2024.11.006
NLM
Silva DLF da, Duarte BKL, Oliveira YC de, Piaia C, Aragao JSR, Chapchap EC, Carvalho MEAJ de, Velloso EDRP, Rocha VG, Rego EM. The impact of clinical features on survival and relapse of patients diagnosed with T-cell acute lymphoblastic leukemia: a multicenter cohort study [Internet]. Clinical lymphoma myeloma & leukemia. 2025 ; 25( 4): 258-264.[citado 2025 nov. 03 ] Available from: https://observatorio.fm.usp.br/handle/OPI/84778
Vancouver
Silva DLF da, Duarte BKL, Oliveira YC de, Piaia C, Aragao JSR, Chapchap EC, Carvalho MEAJ de, Velloso EDRP, Rocha VG, Rego EM. The impact of clinical features on survival and relapse of patients diagnosed with T-cell acute lymphoblastic leukemia: a multicenter cohort study [Internet]. Clinical lymphoma myeloma & leukemia. 2025 ; 25( 4): 258-264.[citado 2025 nov. 03 ] Available from: https://observatorio.fm.usp.br/handle/OPI/84778
Artigo de periodico
Clinical characteristics and outcomes of Brazilian patients with duodenal-type follicular lymphoma: a multicenter retrospective study (2025)
Duffles, Guilherme; Braga, Arthur; Silveira, Talita; Novis, Yana; Arrais, Celso; Tucunduva, Luciana; Fonseca, Ana Rita; Borducchi, Davimar; Rego, Eduardo Magalhães ; Rocha, Vanderson Geraldo
Source: Leukemia & lymphoma. Unidade: FM
Subjects: DUODENO, LINFOMA, NEOPLASIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DUFFLES, Guilherme et al. Clinical characteristics and outcomes of Brazilian patients with duodenal-type follicular lymphoma: a multicenter retrospective study. Leukemia & lymphoma, v. 66, n. 1, p. 95-101, 2025Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/82748. Acesso em: 03 nov. 2025.
APA
Duffles, G., Braga, A., Silveira, T., Novis, Y., Arrais, C., Tucunduva, L., et al. (2025). Clinical characteristics and outcomes of Brazilian patients with duodenal-type follicular lymphoma: a multicenter retrospective study. Leukemia & lymphoma, 66( 1), 95-101. doi:10.1080/10428194.2024.2401098
NLM
Duffles G, Braga A, Silveira T, Novis Y, Arrais C, Tucunduva L, Fonseca AR, Borducchi D, Rego EM, Rocha VG. Clinical characteristics and outcomes of Brazilian patients with duodenal-type follicular lymphoma: a multicenter retrospective study [Internet]. Leukemia & lymphoma. 2025 ; 66( 1): 95-101.[citado 2025 nov. 03 ] Available from: https://observatorio.fm.usp.br/handle/OPI/82748
Vancouver
Duffles G, Braga A, Silveira T, Novis Y, Arrais C, Tucunduva L, Fonseca AR, Borducchi D, Rego EM, Rocha VG. Clinical characteristics and outcomes of Brazilian patients with duodenal-type follicular lymphoma: a multicenter retrospective study [Internet]. Leukemia & lymphoma. 2025 ; 66( 1): 95-101.[citado 2025 nov. 03 ] Available from: https://observatorio.fm.usp.br/handle/OPI/82748
Artigo de periodico
Assessing the role of bronchoscopy in the management of patients with acute leukemia-a transversal study and proposal of evaluation (2025)
Oliveira, Vanildo Rodrigues de; Cano, Carlos Wilson de Alencar; Feitosa, Jose Vivaldo Moreira; Barreto, Guilherme Carneiro; Mendes, Fernanda Rodrigues; Melo, Raphael Costa Bandeira de; Velloso, Elvira Deolinda Rodrigues Pereira ; Rocha, Vanderson Geraldo ; Rego, Eduardo Magalhães ; Silva, Wellington Fernandes da
Source: Hematology Transfusion and Cell Therapy. Unidade: FM
Subjects: LEUCEMIA MIELOIDE AGUDA, QUIMIOTERAPIA, FENÓTIPOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OLIVEIRA, Vanildo Rodrigues de et al. Assessing the role of bronchoscopy in the management of patients with acute leukemia-a transversal study and proposal of evaluation. Hematology Transfusion and Cell Therapy, v. 47, n. 1, 2025Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/84796. Acesso em: 03 nov. 2025.
APA
Oliveira, V. R. de, Cano, C. W. de A., Feitosa, J. V. M., Barreto, G. C., Mendes, F. R., Melo, R. C. B. de, et al. (2025). Assessing the role of bronchoscopy in the management of patients with acute leukemia-a transversal study and proposal of evaluation. Hematology Transfusion and Cell Therapy, 47( 1). doi:10.1016/j.htct.2025.103741
NLM
Oliveira VR de, Cano CW de A, Feitosa JVM, Barreto GC, Mendes FR, Melo RCB de, Velloso EDRP, Rocha VG, Rego EM, Silva WF da. Assessing the role of bronchoscopy in the management of patients with acute leukemia-a transversal study and proposal of evaluation [Internet]. Hematology Transfusion and Cell Therapy. 2025 ; 47( 1):[citado 2025 nov. 03 ] Available from: https://observatorio.fm.usp.br/handle/OPI/84796
Vancouver
Oliveira VR de, Cano CW de A, Feitosa JVM, Barreto GC, Mendes FR, Melo RCB de, Velloso EDRP, Rocha VG, Rego EM, Silva WF da. Assessing the role of bronchoscopy in the management of patients with acute leukemia-a transversal study and proposal of evaluation [Internet]. Hematology Transfusion and Cell Therapy. 2025 ; 47( 1):[citado 2025 nov. 03 ] Available from: https://observatorio.fm.usp.br/handle/OPI/84796
Artigo de periodico
Potency and efficacy of pharmacological PIP4K2 inhibitors in acute lymphoblastic leukemia (2024)
Lima, Keli ; Nogueira, Frederico Lisboa ; Cipelli, Marcella ; Carvalho, Maria Fernanda Lopes ; Martins, Diego Antonio Pereira ; Silva, Wellington Fernandes da ; Medeiros, Rita de Cássia Cavaglieri ; Nardinelli, Luciana ; Leal, Aline de Medeiros; Velloso, Elvira Deolinda Rodrigues Pereira ; Bendit, Israel ; Camara, Niels Olsen Saraiva ; Schuringa, Jan Jacob ; Machado Neto, João Agostinho ; Rego, Eduardo Magalhães
Source: European Journal of Pharmacology. Unidades: FM, ICB
Subjects: FARMACOLOGIA, IMUNOLOGIA, ANTINEOPLÁSICOS, SOBREVIVÊNCIA CELULAR, INIBIDORES DE ENZIMAS, PROTEÍNAS QUINASES, PROTEÍNAS PROTO-ONCOGÊNICAS, NEOPLASIAS POR TIPO HISTOLÓGICO, LEUCEMIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LIMA, Keli et al. Potency and efficacy of pharmacological PIP4K2 inhibitors in acute lymphoblastic leukemia. European Journal of Pharmacology, v. 977, p. 11 , 2024Tradução . . Disponível em: https://doi.org/10.1016/j.ejphar.2024.176723. Acesso em: 03 nov. 2025.
APA
Lima, K., Nogueira, F. L., Cipelli, M., Carvalho, M. F. L., Martins, D. A. P., Silva, W. F. da, et al. (2024). Potency and efficacy of pharmacological PIP4K2 inhibitors in acute lymphoblastic leukemia. European Journal of Pharmacology, 977, 11 . doi:10.1016/j.ejphar.2024.176723
NLM
Lima K, Nogueira FL, Cipelli M, Carvalho MFL, Martins DAP, Silva WF da, Medeiros R de CC, Nardinelli L, Leal A de M, Velloso EDRP, Bendit I, Camara NOS, Schuringa JJ, Machado Neto JA, Rego EM. Potency and efficacy of pharmacological PIP4K2 inhibitors in acute lymphoblastic leukemia [Internet]. European Journal of Pharmacology. 2024 ; 977 11 .[citado 2025 nov. 03 ] Available from: https://doi.org/10.1016/j.ejphar.2024.176723
Vancouver
Lima K, Nogueira FL, Cipelli M, Carvalho MFL, Martins DAP, Silva WF da, Medeiros R de CC, Nardinelli L, Leal A de M, Velloso EDRP, Bendit I, Camara NOS, Schuringa JJ, Machado Neto JA, Rego EM. Potency and efficacy of pharmacological PIP4K2 inhibitors in acute lymphoblastic leukemia [Internet]. European Journal of Pharmacology. 2024 ; 977 11 .[citado 2025 nov. 03 ] Available from: https://doi.org/10.1016/j.ejphar.2024.176723
Trabalho de evento-resumo periodico
Impact of Ph-like gene signatures on clinical outcomes in adult B-all patients in Resource-Constrained settings (2024)
Lima, Keli ; Rojas, César Alexander Ortiz ; Nogueira, Frederico Lisboa ; Silva, Wellington Fernandes da ; Medeiros, Rita de Cássia Cavaglieri ; Nardinelli, Luciana ; Leal, Aline de Medeiros; Alencar, Alvaro J. ; Mullighan, Charles G. ; Rego, Eduardo Magalhães ; Bendit, Israel ; Velloso, Elvira Deolinda Rodrigues Pereira ; Machado Neto, João Agostinho
Source: Blood. Conference titles: 66th ASH Annual Meeting. Unidades: FM, ICB
Subjects: FARMACOLOGIA, LEUCEMIA, GENÉTICA, VARIAÇÃO GENÉTICA, MUTAÇÃO GENÉTICA, EXPRESSÃO GÊNICA, REAÇÃO EM CADEIA POR POLIMERASE, ESTUDOS DE COORTES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LIMA, Keli et al. Impact of Ph-like gene signatures on clinical outcomes in adult B-all patients in Resource-Constrained settings. Blood. Washington, DC: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://doi.org/10.1182/blood-2024-208763. Acesso em: 03 nov. 2025. , 2024
APA
Lima, K., Rojas, C. A. O., Nogueira, F. L., Silva, W. F. da, Medeiros, R. de C. C., Nardinelli, L., et al. (2024). Impact of Ph-like gene signatures on clinical outcomes in adult B-all patients in Resource-Constrained settings. Blood. Washington, DC: Faculdade de Medicina, Universidade de São Paulo. doi:10.1182/blood-2024-208763
NLM
Lima K, Rojas CAO, Nogueira FL, Silva WF da, Medeiros R de CC, Nardinelli L, Leal A de M, Alencar AJ, Mullighan CG, Rego EM, Bendit I, Velloso EDRP, Machado Neto JA. Impact of Ph-like gene signatures on clinical outcomes in adult B-all patients in Resource-Constrained settings [Internet]. Blood. 2024 ; 144( supl. 1): 2802-2803.[citado 2025 nov. 03 ] Available from: https://doi.org/10.1182/blood-2024-208763
Vancouver
Lima K, Rojas CAO, Nogueira FL, Silva WF da, Medeiros R de CC, Nardinelli L, Leal A de M, Alencar AJ, Mullighan CG, Rego EM, Bendit I, Velloso EDRP, Machado Neto JA. Impact of Ph-like gene signatures on clinical outcomes in adult B-all patients in Resource-Constrained settings [Internet]. Blood. 2024 ; 144( supl. 1): 2802-2803.[citado 2025 nov. 03 ] Available from: https://doi.org/10.1182/blood-2024-208763
Artigo de periodico-carta/editorial
ARHGAP6 transcript levels are associated with molecular risk and impact survival outcomes in acute myeloid leukemia (2024)
Silva, Jean Carlos Lipreri da ; Silva, Juan Luiz Coelho da ; Vicari, Hugo Passos ; Lima, Keli ; Rego, Eduardo Magalhães ; Traina, Fabiola ; Machado Neto, João Agostinho
Source: Hematology, Transfusion and Cell Therapy. Unidades: FM, FMRP, ICB
Subjects: FARMACOLOGIA, LEUCEMIA MIELOIDE AGUDA, MEDULA ÓSSEA, CÉLULAS SANGUÍNEAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Jean Carlos Lipreri da et al. ARHGAP6 transcript levels are associated with molecular risk and impact survival outcomes in acute myeloid leukemia. Hematology, Transfusion and Cell Therapy. São José do Rio Preto: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://doi.org/10.1016/j.htct.2023.06.004. Acesso em: 03 nov. 2025. , 2024
APA
Silva, J. C. L. da, Silva, J. L. C. da, Vicari, H. P., Lima, K., Rego, E. M., Traina, F., & Machado Neto, J. A. (2024). ARHGAP6 transcript levels are associated with molecular risk and impact survival outcomes in acute myeloid leukemia. Hematology, Transfusion and Cell Therapy. São José do Rio Preto: Faculdade de Medicina, Universidade de São Paulo. doi:10.1016/j.htct.2023.06.004
NLM
Silva JCL da, Silva JLC da, Vicari HP, Lima K, Rego EM, Traina F, Machado Neto JA. ARHGAP6 transcript levels are associated with molecular risk and impact survival outcomes in acute myeloid leukemia [Internet]. Hematology, Transfusion and Cell Therapy. 2024 ; 46( 1): 105-106.[citado 2025 nov. 03 ] Available from: https://doi.org/10.1016/j.htct.2023.06.004
Vancouver
Silva JCL da, Silva JLC da, Vicari HP, Lima K, Rego EM, Traina F, Machado Neto JA. ARHGAP6 transcript levels are associated with molecular risk and impact survival outcomes in acute myeloid leukemia [Internet]. Hematology, Transfusion and Cell Therapy. 2024 ; 46( 1): 105-106.[citado 2025 nov. 03 ] Available from: https://doi.org/10.1016/j.htct.2023.06.004
Artigo de periodico
NT157 exhibits antineoplastic effects by targeting IRS and STAT3/5 signaling in multiple myeloma (2024)
Queiroz, Gustavo Nery de ; Lima, Keli ; Miranda, Lívia Bassani Lins De ; Traina, Fabiola ; Rego, Eduardo Magalhães ; Machado Neto, João Agostinho
Source: Hematology, Transfusion and Cell Therapy ISSN:2531-1387. Unidades: FM, FMRP, ICB
Subjects: FARMACOLOGIA, MIELOMA MÚLTIPLO, NEOPLASIAS POR TIPO HISTOLÓGICO, PROLIFERAÇÃO CELULAR, ANTINEOPLÁSICOS, CÉLULAS CULTIVADAS DE TUMOR, EXPRESSÃO GÊNICA, ONCOGENES, APOPTOSE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
QUEIROZ, Gustavo Nery de et al. NT157 exhibits antineoplastic effects by targeting IRS and STAT3/5 signaling in multiple myeloma. Hematology, Transfusion and Cell Therapy ISSN:2531-1387, v. 46, n. supl. 6, p. S112-S121, 2024Tradução . . Disponível em: https://doi.org/10.1016/j.htct.2024.02.017. Acesso em: 03 nov. 2025.
APA
Queiroz, G. N. de, Lima, K., Miranda, L. B. L. D., Traina, F., Rego, E. M., & Machado Neto, J. A. (2024). NT157 exhibits antineoplastic effects by targeting IRS and STAT3/5 signaling in multiple myeloma. Hematology, Transfusion and Cell Therapy ISSN:2531-1387, 46( supl. 6), S112-S121. doi:10.1016/j.htct.2024.02.017
NLM
Queiroz GN de, Lima K, Miranda LBLD, Traina F, Rego EM, Machado Neto JA. NT157 exhibits antineoplastic effects by targeting IRS and STAT3/5 signaling in multiple myeloma [Internet]. Hematology, Transfusion and Cell Therapy ISSN:2531-1387. 2024 ; 46( supl. 6): S112-S121.[citado 2025 nov. 03 ] Available from: https://doi.org/10.1016/j.htct.2024.02.017
Vancouver
Queiroz GN de, Lima K, Miranda LBLD, Traina F, Rego EM, Machado Neto JA. NT157 exhibits antineoplastic effects by targeting IRS and STAT3/5 signaling in multiple myeloma [Internet]. Hematology, Transfusion and Cell Therapy ISSN:2531-1387. 2024 ; 46( supl. 6): S112-S121.[citado 2025 nov. 03 ] Available from: https://doi.org/10.1016/j.htct.2024.02.017
Artigo de periodico-carta/editorial
Therapeutic plasma exchange and HLA desensitization.[Editorial] (2024)
Rego, Eduardo Magalhaes
Source: Hematology transfusion and cell therapy. Unidade: FM
Subjects: EDITORIAL, DOENÇAS HEMATOLÓGICAS, ONCOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
REGO, Eduardo Magalhaes. Therapeutic plasma exchange and HLA desensitization.[Editorial]. Hematology transfusion and cell therapy. Amsterdam: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://observatorio.fm.usp.br/handle/OPI/76798. Acesso em: 03 nov. 2025. , 2024
APA
Rego, E. M. (2024). Therapeutic plasma exchange and HLA desensitization.[Editorial]. Hematology transfusion and cell therapy. Amsterdam: Faculdade de Medicina, Universidade de São Paulo. doi:10.1016/j.htct.2024.02.001
NLM
Rego EM. Therapeutic plasma exchange and HLA desensitization.[Editorial] [Internet]. Hematology transfusion and cell therapy. 2024 ; 46( 1): 1-2.[citado 2025 nov. 03 ] Available from: https://observatorio.fm.usp.br/handle/OPI/76798
Vancouver
Rego EM. Therapeutic plasma exchange and HLA desensitization.[Editorial] [Internet]. Hematology transfusion and cell therapy. 2024 ; 46( 1): 1-2.[citado 2025 nov. 03 ] Available from: https://observatorio.fm.usp.br/handle/OPI/76798
Artigo de periodico-carta/editorial
Clinical significance of Philadelphia-like-related genes in a resource-constrained setting of adult B-acute lymphoblastic leukemia patients (2024)
Lima, Keli ; Rojas, César Alexander Ortiz ; Nogueira, Frederico Lisboa ; Silva, Wellington Fernandes da ; Cavaglieri, Rita de Cássia ; Nardinelli, Luciana ; Leal, Aline de Medeiros; Bendit, Israel ; Alencar, Alvaro; Mullighan, Charles G. ; Rego, Eduardo Magalhães ; Velloso, Elvira Deolinda Rodrigues Pereira ; Machado Neto, João Agostinho
Source: EJHaem. Unidades: FM, ICB, FCF
Subjects: FARMACOLOGIA, LEUCEMIA, MUTAÇÃO GENÉTICA, NEOPLASIAS POR LOCALIZAÇÃO, MEDULA ÓSSEA, CÉLULAS SANGUÍNEAS, EXPRESSÃO GÊNICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LIMA, Keli et al. Clinical significance of Philadelphia-like-related genes in a resource-constrained setting of adult B-acute lymphoblastic leukemia patients. EJHaem. Hoboken, NJ: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://doi.org/10.1002/jha2.1030. Acesso em: 03 nov. 2025. , 2024
APA
Lima, K., Rojas, C. A. O., Nogueira, F. L., Silva, W. F. da, Cavaglieri, R. de C., Nardinelli, L., et al. (2024). Clinical significance of Philadelphia-like-related genes in a resource-constrained setting of adult B-acute lymphoblastic leukemia patients. EJHaem. Hoboken, NJ: Faculdade de Medicina, Universidade de São Paulo. doi:10.1002/jha2.1030
NLM
Lima K, Rojas CAO, Nogueira FL, Silva WF da, Cavaglieri R de C, Nardinelli L, Leal A de M, Bendit I, Alencar A, Mullighan CG, Rego EM, Velloso EDRP, Machado Neto JA. Clinical significance of Philadelphia-like-related genes in a resource-constrained setting of adult B-acute lymphoblastic leukemia patients [Internet]. EJHaem. 2024 ; 5( 6): 1366-1369.[citado 2025 nov. 03 ] Available from: https://doi.org/10.1002/jha2.1030
Vancouver
Lima K, Rojas CAO, Nogueira FL, Silva WF da, Cavaglieri R de C, Nardinelli L, Leal A de M, Bendit I, Alencar A, Mullighan CG, Rego EM, Velloso EDRP, Machado Neto JA. Clinical significance of Philadelphia-like-related genes in a resource-constrained setting of adult B-acute lymphoblastic leukemia patients [Internet]. EJHaem. 2024 ; 5( 6): 1366-1369.[citado 2025 nov. 03 ] Available from: https://doi.org/10.1002/jha2.1030
Artigo de periodico
Acute myeloid leukemia-derived bone marrow mesenchymal cells exhibit improved support for leukemic cell proliferation (2024)
Nascimento, Mariane Cristina do ; Pereira-Martins, Diego Antonio ; Rego, Eduardo Magalhães ; Machado Neto, João Agostinho
Source: Hematology, Transfusion and Cell Therapy. Unidades: FM, ICB
Subjects: FARMACOLOGIA, MEDULA ÓSSEA, LEUCEMIA MIELOIDE AGUDA, CÉLULAS-TRONCO, PROLIFERAÇÃO CELULAR, EXPRESSÃO GÊNICA, SEQUENCIAMENTO GENÉTICO, MITOCÔNDRIAS, ESTRESSE OXIDATIVO, METABOLISMO CELULAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NASCIMENTO, Mariane Cristina do et al. Acute myeloid leukemia-derived bone marrow mesenchymal cells exhibit improved support for leukemic cell proliferation. Hematology, Transfusion and Cell Therapy, v. 46, n. Suppl. 6, p. S48-S52, 2024Tradução . . Disponível em: https://doi.org/10.1016/j.htct.2023.10.007. Acesso em: 03 nov. 2025.
APA
Nascimento, M. C. do, Pereira-Martins, D. A., Rego, E. M., & Machado Neto, J. A. (2024). Acute myeloid leukemia-derived bone marrow mesenchymal cells exhibit improved support for leukemic cell proliferation. Hematology, Transfusion and Cell Therapy, 46( Suppl. 6), S48-S52. doi:10.1016/j.htct.2023.10.007
NLM
Nascimento MC do, Pereira-Martins DA, Rego EM, Machado Neto JA. Acute myeloid leukemia-derived bone marrow mesenchymal cells exhibit improved support for leukemic cell proliferation [Internet]. Hematology, Transfusion and Cell Therapy. 2024 ; 46( Suppl. 6): S48-S52.[citado 2025 nov. 03 ] Available from: https://doi.org/10.1016/j.htct.2023.10.007
Vancouver
Nascimento MC do, Pereira-Martins DA, Rego EM, Machado Neto JA. Acute myeloid leukemia-derived bone marrow mesenchymal cells exhibit improved support for leukemic cell proliferation [Internet]. Hematology, Transfusion and Cell Therapy. 2024 ; 46( Suppl. 6): S48-S52.[citado 2025 nov. 03 ] Available from: https://doi.org/10.1016/j.htct.2023.10.007
Artigo de periodico
Patterns and prognostic impact of CNS infiltration in adults with newly diagnosed acute lymphoblastic leukemia (2024)
Perruso, Luiza Lapolla; Velloso, Elvira Deolinda Rodrigues Pereira ; Rocha, Vanderson Geraldo ; Rego, Eduardo Magalhães ; Silva, Wellington Fernandes
Source: Annals of hematology. Unidade: FM
Subjects: LEUCEMIA, SISTEMA NERVOSO CENTRAL, PROGNÓSTICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PERRUSO, Luiza Lapolla et al. Patterns and prognostic impact of CNS infiltration in adults with newly diagnosed acute lymphoblastic leukemia. Annals of hematology, v. 103, n. 6, p. 2033-2039, 2024Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/76787. Acesso em: 03 nov. 2025.
APA
Perruso, L. L., Velloso, E. D. R. P., Rocha, V. G., Rego, E. M., & Silva, W. F. (2024). Patterns and prognostic impact of CNS infiltration in adults with newly diagnosed acute lymphoblastic leukemia. Annals of hematology, 103( 6), 2033-2039. doi:10.1007/s00277-023-05609-4
NLM
Perruso LL, Velloso EDRP, Rocha VG, Rego EM, Silva WF. Patterns and prognostic impact of CNS infiltration in adults with newly diagnosed acute lymphoblastic leukemia [Internet]. Annals of hematology. 2024 ; 103( 6): 2033-2039.[citado 2025 nov. 03 ] Available from: https://observatorio.fm.usp.br/handle/OPI/76787
Vancouver
Perruso LL, Velloso EDRP, Rocha VG, Rego EM, Silva WF. Patterns and prognostic impact of CNS infiltration in adults with newly diagnosed acute lymphoblastic leukemia [Internet]. Annals of hematology. 2024 ; 103( 6): 2033-2039.[citado 2025 nov. 03 ] Available from: https://observatorio.fm.usp.br/handle/OPI/76787
Artigo de periodico
Comprehensive analysis of the HCK gene in myeloid neoplasms: insights into biological functions, prognosis, and response to antineoplastic agents (2024)
Carvalho, Maria Fernanda Lopes ; Almeida, Bruna Oliveira de ; Bueno, Maura Lima Pereira ; Vicari, Hugo Passos ; Lima, Keli ; Rego, Eduardo Magalhães ; Roversi, Fernanda Marconi ; Machado Neto, João Agostinho
Source: Hematology, Transfusion and Cell Therapy. Unidades: FM, ICB
Assunto: FARMACOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CARVALHO, Maria Fernanda Lopes et al. Comprehensive analysis of the HCK gene in myeloid neoplasms: insights into biological functions, prognosis, and response to antineoplastic agents. Hematology, Transfusion and Cell Therapy, v. 46, n. 3, p. 273-282, 2024Tradução . . Disponível em: https://doi.org/10.1016/j.htct.2023.11.007. Acesso em: 03 nov. 2025.
APA
Carvalho, M. F. L., Almeida, B. O. de, Bueno, M. L. P., Vicari, H. P., Lima, K., Rego, E. M., et al. (2024). Comprehensive analysis of the HCK gene in myeloid neoplasms: insights into biological functions, prognosis, and response to antineoplastic agents. Hematology, Transfusion and Cell Therapy, 46( 3), 273-282. doi:10.1016/j.htct.2023.11.007
NLM
Carvalho MFL, Almeida BO de, Bueno MLP, Vicari HP, Lima K, Rego EM, Roversi FM, Machado Neto JA. Comprehensive analysis of the HCK gene in myeloid neoplasms: insights into biological functions, prognosis, and response to antineoplastic agents [Internet]. Hematology, Transfusion and Cell Therapy. 2024 ; 46( 3): 273-282.[citado 2025 nov. 03 ] Available from: https://doi.org/10.1016/j.htct.2023.11.007
Vancouver
Carvalho MFL, Almeida BO de, Bueno MLP, Vicari HP, Lima K, Rego EM, Roversi FM, Machado Neto JA. Comprehensive analysis of the HCK gene in myeloid neoplasms: insights into biological functions, prognosis, and response to antineoplastic agents [Internet]. Hematology, Transfusion and Cell Therapy. 2024 ; 46( 3): 273-282.[citado 2025 nov. 03 ] Available from: https://doi.org/10.1016/j.htct.2023.11.007
Artigo de periodico
All-trans retinoic acid potentiates cell death induced by quizartinib in acute myeloid leukemia with FLT3-ITD mutations (2024)
Sánchez-Mendoza, Silvia Elena; Deus-Wagatsuma, Virginia Mara de; Nascimento, Mariane Cristina do; Lima, Keli ; Machado Neto, João Agostinho ; Djavaheri-Mergny, Mojgan; Rego, Eduardo Magalhães
Source: Annals of Hematology. Unidades: ICB, FM
Subjects: FARMACOLOGIA, LEUCEMIA MIELOIDE AGUDA, APOPTOSE, QUIMIOTERAPIA COMBINADA, PROTEÍNAS QUINASES, ANTINEOPLÁSICOS, MUTAÇÃO GENÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SÁNCHEZ-MENDOZA, Silvia Elena et al. All-trans retinoic acid potentiates cell death induced by quizartinib in acute myeloid leukemia with FLT3-ITD mutations. Annals of Hematology, v. 103, p. 5405-5416, 2024Tradução . . Disponível em: https://doi.org/10.1007/s00277-024-06089-w. Acesso em: 03 nov. 2025.
APA
Sánchez-Mendoza, S. E., Deus-Wagatsuma, V. M. de, Nascimento, M. C. do, Lima, K., Machado Neto, J. A., Djavaheri-Mergny, M., & Rego, E. M. (2024). All-trans retinoic acid potentiates cell death induced by quizartinib in acute myeloid leukemia with FLT3-ITD mutations. Annals of Hematology, 103, 5405-5416. doi:10.1007/s00277-024-06089-w
NLM
Sánchez-Mendoza SE, Deus-Wagatsuma VM de, Nascimento MC do, Lima K, Machado Neto JA, Djavaheri-Mergny M, Rego EM. All-trans retinoic acid potentiates cell death induced by quizartinib in acute myeloid leukemia with FLT3-ITD mutations [Internet]. Annals of Hematology. 2024 ; 103 5405-5416.[citado 2025 nov. 03 ] Available from: https://doi.org/10.1007/s00277-024-06089-w
Vancouver
Sánchez-Mendoza SE, Deus-Wagatsuma VM de, Nascimento MC do, Lima K, Machado Neto JA, Djavaheri-Mergny M, Rego EM. All-trans retinoic acid potentiates cell death induced by quizartinib in acute myeloid leukemia with FLT3-ITD mutations [Internet]. Annals of Hematology. 2024 ; 103 5405-5416.[citado 2025 nov. 03 ] Available from: https://doi.org/10.1007/s00277-024-06089-w
Artigo de periodico
Antineoplastic effects of pharmacological inhibitors of aurora kinases in CSF3R^T618I-driven cells (2024)
Parducci, Natalia Sudan ; Garnique, Anali Del Milagro Bernabe ; Lima, Keli ; Carlos, Jorge Antonio Elias Godoy ; Fonseca, Natasha Peixoto ; Miranda, Lívia Bassani Lins De ; Almeida, Bruna Oliveira de ; Rego, Eduardo Magalhães ; Traina, Fabiola ; Machado Neto, João Agostinho
Source: Blood Cells Molecules and Diseases. Unidades: FMRP, FM, ICB
Subjects: PROTEÍNAS QUINASES, ANTINEOPLÁSICOS, BAINHA DE MIELINA, MUTAÇÃO GENÉTICA, LEUCEMIA MIELOIDE AGUDA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PARDUCCI, Natalia Sudan et al. Antineoplastic effects of pharmacological inhibitors of aurora kinases in CSF3R^T618I-driven cells. Blood Cells Molecules and Diseases, v. 104, 2024Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/58756. Acesso em: 03 nov. 2025.
APA
Parducci, N. S., Garnique, A. D. M. B., Lima, K., Carlos, J. A. E. G., Fonseca, N. P., Miranda, L. B. L. D., et al. (2024). Antineoplastic effects of pharmacological inhibitors of aurora kinases in CSF3R^T618I-driven cells. Blood Cells Molecules and Diseases, 104. doi:10.1016/j.bcmd.2023.102799
NLM
Parducci NS, Garnique ADMB, Lima K, Carlos JAEG, Fonseca NP, Miranda LBLD, Almeida BO de, Rego EM, Traina F, Machado Neto JA. Antineoplastic effects of pharmacological inhibitors of aurora kinases in CSF3R^T618I-driven cells [Internet]. Blood Cells Molecules and Diseases. 2024 ; 104[citado 2025 nov. 03 ] Available from: https://observatorio.fm.usp.br/handle/OPI/58756
Vancouver
Parducci NS, Garnique ADMB, Lima K, Carlos JAEG, Fonseca NP, Miranda LBLD, Almeida BO de, Rego EM, Traina F, Machado Neto JA. Antineoplastic effects of pharmacological inhibitors of aurora kinases in CSF3R^T618I-driven cells [Internet]. Blood Cells Molecules and Diseases. 2024 ; 104[citado 2025 nov. 03 ] Available from: https://observatorio.fm.usp.br/handle/OPI/58756
Parte de monografia/livro
Tromboembolismo venoso (2024)
Rego, Eduardo Magalhães ; Melo,Raphael Costa Bandeira de; Costa Neto, Abel da; Farias, Cássio Lins Gil de; Ribeiro, Lucas Trindade Cantú
Source: O paciente cirúrgico de alto risco :condutas no perioperatório. Unidade: FM
Assunto: TROMBOEMBOLISMO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
REGO, Eduardo Magalhães et al. Tromboembolismo venoso. O paciente cirúrgico de alto risco :condutas no perioperatório. Tradução . Rio de Janeiro: Atheneu, 2024. . . Acesso em: 03 nov. 2025.
APA
Rego, E. M., Melo, R. C. B. de, Costa Neto, A. da, Farias, C. L. G. de, & Ribeiro, L. T. C. (2024). Tromboembolismo venoso. In O paciente cirúrgico de alto risco :condutas no perioperatório. Rio de Janeiro: Atheneu.
NLM
Rego EM, Melo RCB de, Costa Neto A da, Farias CLG de, Ribeiro LTC. Tromboembolismo venoso. In: O paciente cirúrgico de alto risco :condutas no perioperatório. Rio de Janeiro: Atheneu; 2024. [citado 2025 nov. 03 ]
Vancouver
Rego EM, Melo RCB de, Costa Neto A da, Farias CLG de, Ribeiro LTC. Tromboembolismo venoso. In: O paciente cirúrgico de alto risco :condutas no perioperatório. Rio de Janeiro: Atheneu; 2024. [citado 2025 nov. 03 ]
Artigo de periodico
Real-world imatinib mesylate treatment in patients with chronic myeloid leukemia: the importance of molecular monitoring and the early molecular response (2023)
Ferreira, Amanda Pifano Soares; Seguro, Fernanda Salles; Abdo, Andre Ramires Neder; Santos, Fernanda Maria; Maciel, Felipe Vieira Rodrigues; Nardinelli, Luciana; Giorgi, Ricardo Rodrigues; Ruiz, Antonio Roberto Lancha; Rego, Eduardo Magalhães ; Rocha, Vanderson Geraldo
Source: Annals of hematology. Unidade: FM
Subjects: DOENÇA CRÔNICA, LEUCEMIA MIELOIDE, SOBREVIDA, ESTUDOS MULTICÊNTRICOS, ESTUDOS RANDOMIZADOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FERREIRA, Amanda Pifano Soares et al. Real-world imatinib mesylate treatment in patients with chronic myeloid leukemia: the importance of molecular monitoring and the early molecular response. Annals of hematology, v. 102, n. 7, p. 1761-1771, 2023Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/54584. Acesso em: 03 nov. 2025.
APA
Ferreira, A. P. S., Seguro, F. S., Abdo, A. R. N., Santos, F. M., Maciel, F. V. R., Nardinelli, L., et al. (2023). Real-world imatinib mesylate treatment in patients with chronic myeloid leukemia: the importance of molecular monitoring and the early molecular response. Annals of hematology, 102( 7), 1761-1771. doi:10.1007/s00277-023-05189-3
NLM
Ferreira APS, Seguro FS, Abdo ARN, Santos FM, Maciel FVR, Nardinelli L, Giorgi RR, Ruiz ARL, Rego EM, Rocha VG. Real-world imatinib mesylate treatment in patients with chronic myeloid leukemia: the importance of molecular monitoring and the early molecular response [Internet]. Annals of hematology. 2023 ; 102( 7): 1761-1771.[citado 2025 nov. 03 ] Available from: https://observatorio.fm.usp.br/handle/OPI/54584
Vancouver
Ferreira APS, Seguro FS, Abdo ARN, Santos FM, Maciel FVR, Nardinelli L, Giorgi RR, Ruiz ARL, Rego EM, Rocha VG. Real-world imatinib mesylate treatment in patients with chronic myeloid leukemia: the importance of molecular monitoring and the early molecular response [Internet]. Annals of hematology. 2023 ; 102( 7): 1761-1771.[citado 2025 nov. 03 ] Available from: https://observatorio.fm.usp.br/handle/OPI/54584
Artigo de periodico
Potency and efficacy of pharmacological PIP4K2 inhibitors in acute lymphoblastic leukemia (2023)
Lima, Keli ; Carvalho, Maria Fernanda Lopes ; Martins, Diego Antonio Pereira ; Silva, Wellington Fernandes da; Nascimento, Mariane Cristina do ; Miranda, Lívia Bassani Lins De ; Medeiros, Rita de Cássia Cavaglieri ; Nardinelli, Luciana; Leal, Aline de Medeiros; Velloso, Elvira Deolinda Rodrigues Pereira ; Bendit, Israel ; Schuringa, Jan Jacob ; Rego, Eduardo Magalhães ; Machado Neto, João Agostinho
Source: Blood. Conference titles: 65th ASH Annual Meeting Abstracts. Unidades: FM, ICB, FMRP
Subjects: HEMATOLOGIA, LEUCEMIA, LINFOMA, DOENÇAS SANGUÍNEAS E LINFÁTICAS, INIBIDORES QUÍMICOS, ESTUDOS DE COORTES, EXPRESSÃO GÊNICA, REAÇÃO EM CADEIA POR POLIMERASE, WESTERN BLOTTING, CITOMETRIA DE FLUXO, NEOPLASIAS POR TIPO HISTOLÓGICO, ANTINEOPLÁSICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LIMA, Keli et al. Potency and efficacy of pharmacological PIP4K2 inhibitors in acute lymphoblastic leukemia. Blood, v. 142, p. 5886, 2023Tradução . . Disponível em: https://doi.org/10.1182/blood-2023-189786. Acesso em: 03 nov. 2025.
APA
Lima, K., Carvalho, M. F. L., Martins, D. A. P., Silva, W. F. da, Nascimento, M. C. do, Miranda, L. B. L. D., et al. (2023). Potency and efficacy of pharmacological PIP4K2 inhibitors in acute lymphoblastic leukemia. Blood, 142, 5886. doi:10.1182/blood-2023-189786
NLM
Lima K, Carvalho MFL, Martins DAP, Silva WF da, Nascimento MC do, Miranda LBLD, Medeiros R de CC, Nardinelli L, Leal A de M, Velloso EDRP, Bendit I, Schuringa JJ, Rego EM, Machado Neto JA. Potency and efficacy of pharmacological PIP4K2 inhibitors in acute lymphoblastic leukemia [Internet]. Blood. 2023 ; 142 5886.[citado 2025 nov. 03 ] Available from: https://doi.org/10.1182/blood-2023-189786
Vancouver
Lima K, Carvalho MFL, Martins DAP, Silva WF da, Nascimento MC do, Miranda LBLD, Medeiros R de CC, Nardinelli L, Leal A de M, Velloso EDRP, Bendit I, Schuringa JJ, Rego EM, Machado Neto JA. Potency and efficacy of pharmacological PIP4K2 inhibitors in acute lymphoblastic leukemia [Internet]. Blood. 2023 ; 142 5886.[citado 2025 nov. 03 ] Available from: https://doi.org/10.1182/blood-2023-189786
Artigo de periodico
The multikinase inhibitor AD80 induces mitotic catastrophe and autophagy in pancreatic cancer cells (2023)
Lima, Keli ; Miranda, Lívia Bassani Lins De ; Garnique, Anali Del Milagro Bernabe ; Almeida, Bruna Oliveira de ; Nascimento, Mariane Cristina do; Alcântara, Guilherme Augusto Sousa; Machado-Santelli, Glaucia Maria ; Rego, Eduardo Magalhães ; Machado Neto, João Agostinho
Source: Cancers. Unidades: ICB, FM
Subjects: BIOLOGIA CELULAR, FARMACOLOGIA, CÉLULAS CULTIVADAS DE TUMOR, NEOPLASIAS PANCREÁTICAS, INIBIDORES DE ENZIMAS, ANTINEOPLÁSICOS, DANO AO DNA, APOPTOSE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LIMA, Keli et al. The multikinase inhibitor AD80 induces mitotic catastrophe and autophagy in pancreatic cancer cells. Cancers, v. 15, n. 15, p. 14 , 2023Tradução . . Disponível em: https://doi.org/10.3390/cancers15153866. Acesso em: 03 nov. 2025.
APA
Lima, K., Miranda, L. B. L. D., Garnique, A. D. M. B., Almeida, B. O. de, Nascimento, M. C. do, Alcântara, G. A. S., et al. (2023). The multikinase inhibitor AD80 induces mitotic catastrophe and autophagy in pancreatic cancer cells. Cancers, 15( 15), 14 . doi:10.3390/cancers15153866
NLM
Lima K, Miranda LBLD, Garnique ADMB, Almeida BO de, Nascimento MC do, Alcântara GAS, Machado-Santelli GM, Rego EM, Machado Neto JA. The multikinase inhibitor AD80 induces mitotic catastrophe and autophagy in pancreatic cancer cells [Internet]. Cancers. 2023 ; 15( 15): 14 .[citado 2025 nov. 03 ] Available from: https://doi.org/10.3390/cancers15153866
Vancouver
Lima K, Miranda LBLD, Garnique ADMB, Almeida BO de, Nascimento MC do, Alcântara GAS, Machado-Santelli GM, Rego EM, Machado Neto JA. The multikinase inhibitor AD80 induces mitotic catastrophe and autophagy in pancreatic cancer cells [Internet]. Cancers. 2023 ; 15( 15): 14 .[citado 2025 nov. 03 ] Available from: https://doi.org/10.3390/cancers15153866
Artigo de periodico
Identification of vulnerabilities for pharmacological inhibition of PIP4K2s in Acute Myeloid Leukemia (2023)
Lima, Keli ; Carvalho, Maria Fernanda Lopes ; Martins, Diego Antonio Pereira ; Nascimento, Mariane Cristina do ; Nogueira, Frederico Lisboa ; Medeiros, Rita de Cássia Cavaglieri ; Schuringa, Jan Jacob ; Rego, Eduardo Magalhães ; Machado Neto, João Agostinho
Source: Blood. Conference titles: 65th ASH Annual Meeting Abstracts. Unidades: FM, ICB, FMRP
Subjects: FARMACOLOGIA, HEMATOLOGIA, LEUCEMIA MIELOIDE AGUDA, QUIMIOTERAPIA COMBINADA, CÉLULAS CULTIVADAS DE TUMOR, PROLIFERAÇÃO CELULAR, NEOPLASIAS POR TIPO HISTOLÓGICO, ANTINEOPLÁSICOS, PROTEÍNAS, CÉLULAS MIELOIDES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LIMA, Keli et al. Identification of vulnerabilities for pharmacological inhibition of PIP4K2s in Acute Myeloid Leukemia. Blood, v. 142, n. Supl. 1, p. 5774, 2023Tradução . . Disponível em: https://doi.org/10.1182/blood-2023-189998. Acesso em: 03 nov. 2025.
APA
Lima, K., Carvalho, M. F. L., Martins, D. A. P., Nascimento, M. C. do, Nogueira, F. L., Medeiros, R. de C. C., et al. (2023). Identification of vulnerabilities for pharmacological inhibition of PIP4K2s in Acute Myeloid Leukemia. Blood, 142( Supl. 1), 5774. doi:10.1182/blood-2023-189998
NLM
Lima K, Carvalho MFL, Martins DAP, Nascimento MC do, Nogueira FL, Medeiros R de CC, Schuringa JJ, Rego EM, Machado Neto JA. Identification of vulnerabilities for pharmacological inhibition of PIP4K2s in Acute Myeloid Leukemia [Internet]. Blood. 2023 ; 142( Supl. 1): 5774.[citado 2025 nov. 03 ] Available from: https://doi.org/10.1182/blood-2023-189998
Vancouver
Lima K, Carvalho MFL, Martins DAP, Nascimento MC do, Nogueira FL, Medeiros R de CC, Schuringa JJ, Rego EM, Machado Neto JA. Identification of vulnerabilities for pharmacological inhibition of PIP4K2s in Acute Myeloid Leukemia [Internet]. Blood. 2023 ; 142( Supl. 1): 5774.[citado 2025 nov. 03 ] Available from: https://doi.org/10.1182/blood-2023-189998

USP Schools

ReP

Filtros

Document Types

USP Schools

Departament

Authors

USP affiliated authors

Date published

Subjects

Source title

Publisher

Conference titles

Countries/Territories

Funding Agencies

Indexado em

Normalized affiliation

Non normalized affiliation

Countries of institutions of collaboration